Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-05

Clinical Trial Update: Effects Of Darbepoetin On Vascular Repair Mechanisms In Kidney Disease The DARBEPC Study

View source ↗

Summary

This update reports on the completed DARBEPC study evaluating the effects of darbepoetin on vascular repair mechanisms in patients with chronic kidney disease a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Darbepoetin alfa (Aranesp) (darbepoetin alfa)

Snippet

Sponsor: University of Michigan | Conditions: Chronic Kidney Disease, Anemia | Status: COMPLETED